Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicarious SurgicalRBOT -7.01% 5-Year Yield-on-Cost % is 0.00 as of Aug. 02, 2026. The stock has 2 warning signs investors should review. Among 319 Medical Devices & Instruments companies, Vicarious Surgical ranks worse than 313479.31% on this metric.
Vicarious Surgical's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Vicarious Surgical's 5-Year Yield-on-Cost % or its related term are showing as below:
RBOT's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.44 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Vicarious Surgical 5-Year Yield-on-Cost % Related Terms
RBOT vs NUWE, ODYY, PFSA: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Vicarious Surgical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicarious Surgical 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Vicarious Surgical's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Vicarious Surgical (RBOT) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vicarious Surgical and its competitors. According to the industry distribution chart, Vicarious Surgical ranks #999999 out of 319 companies in the Medical Devices & Instruments industry.
Is Vicarious Surgical's 5-Year Yield-on-Cost % too high?
Vicarious Surgical's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Vicarious Surgical ranks #999999 out of 319 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Vicarious Surgical's 5-Year Yield-on-Cost % compare to NUWE and ODYY?
According to the Medical Devices & Instruments industry distribution chart, Vicarious Surgical ranks #999999 out of 319 companies for 5-Year Yield-on-Cost %. This places Vicarious Surgical in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.44, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vicarious Surgical and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicarious Surgical's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicarious Surgical stock overvalued right now?
Vicarious Surgical (RBOT) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Vicarious Surgical (RBOT), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicarious Surgical Inc is combining miniaturized robotics, computer science, sensing and 3D visualization to build a new category of intelligent and affordable single-port surgical robots that virtually transport surgeons inside the patient to perform minimally invasive surgery. Its single-port surgical robot, called the Vicarious Surgical System is being developed to provide attractive advantages to hospitals and ambulatory surgical centers, or ASCs, which it believes will drive rapid and widespread adoption. The company operates as one operating segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RBOT has been successfully added to your 
